Creo Medical Group Plc (CREO) Ord GBP0.001
- Add to watchlist
- Create an alert
- This stock can be held in a
34.50p
35.00p
49.00p
£125.61 million
34.50p
34.25p
23.25p
n/a
0.00p (0.00%) Previous:
0.00p
73,412
n/a
5,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2022 | 31/12/2021 |
---|---|---|
Revenue (£m) | 27.17 | 25.16 |
Profit before tax (£m) | (30.98) | (30.34) |
Adjusted EPS (p): | (14.48) | (14.48) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Creo device used in 'groundbreaking' lung cancer procedure
1 March 2024 14:06
-
Creo Medical FY revenues up double digits
7 February 2024 11:49
-
Creo launches 'Speedboat Ultraslim' with first UK procedure
13 December 2023 14:28
-
Holding(s) in Company
20 March 2024 16:52
-
Holding(s) in Company
13 March 2024 15:05
-
LTIP Awards
11 March 2024 14:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.